Life science marketing often involves an abundance of technical information. This is often for good reason – scientists are inquisitive and want to know what they are potentially buying. What amazes me is how often, in the whirlwind of technical information, lists of benefits, and descriptions of products, life science marketers fail to use effective calls to action. Alarmingly frequently, life science marketing materials contain a complete lack of any call to action whatsoever. There have been brochures, product pages on company websites, and a host of other materials where I get to the end and think “so if I’m a customer, how do I go about buying this or making an inquiry?”.
There is no excuse to not have a strong call to action in your marketing materials, be them print, web, or other. Calls to action to not detract from the content of the message, they don’t have to be distracting, and they are incredibly easy to use. Simply think at what point(s) a potential customer would want to place an inquiry or make a purchase and provide them simple, straightforward directions for doing so. If you want them to call to make an inquiry, tell them to call in order to do so. If you’d like them to fill out an online form, provide a link or put the form in a sidebar, etc. If they can purchase online, put an “add to cart” button on your site or direct them to your e-commerce page.
When you get your marketing message in front of potential customers and you have their attention, you have successfully completed one of the most difficult tasks in life science marketing. Don’t waste that opportunity by failing to lead them to the next step in the sale or inquiry process. Continue the engagement by using calls to action which inform them how to continue to the next step in the purchase process and encourage them to do so.
In one of the first posts on our new site we discussed some ways in which life science tools companies can take advantage of a weak dollar, but with a decidedly U.S.-centric focus. With the dollar index hitting a three-year low last Thursday and not far from an all-time low, we decided to revisit the topic, this time with an international focus. While a weaker U.S. dollar is most often a positive for U.S.-based manufacturers, it can pose problems for international companies that want to export into the United States. While there is no way for a company to circumvent the exchange rates, a very weak dollar may present a good time to act on certain cross-border opportunities for some non-U.S. life science companies.
The U.S. Dollar Index (5-year chart)
For non-U.S. distribution companies, the exchange rate probably doesn’t seem so bad. A cheap dollar can be a good time to stock up on inventory from U.S. suppliers. Manufacturers need to look a little harder for a silver lining as their products become effectively more expensive in the U.S. Now, however may be a time to look to the U.S. to source parts, etc. in order to decrease manufacturing costs. If you are willing to bet that the dollar is near a local minimum, you may even want to prepay for items that are sourced within the United States.
Ever think about starting operations inside the U.S.? Now might just be the time. One-time expenses will now be relatively cheap and operating costs will currently be low, allowing your company to mitigate the large capital outflows necessary to begin operations. (shameless self-promotion warning: looking for a way to less expensively start U.S. operations?) Speaking more generally, for non-U.S. companies, now is the time to execute dollar-denominated contracts.
The dollar may not stay weak for long. With expected budget cuts by the U.S. Government and tightening of fiscal policy by the Federal Reserve (including the end of the second round of qualitative easing) imminent, it is likely that the dollar will stabilize at the very least, meaning we are likely near or at low levels. If your bioscience company have a future expense that will be in dollars, you may realize significant savings by pushing that expense forward and executing now.
Going somewhat in step with our previous post on projecting expertise, I’ve noticed a recent trend of life science companies starting or sponsoring unbranded, off-site blogs. I have no problem with using such blogs as a marketing tool so long as the strategy for doing so is properly addressed. There are a lot of potential things that can be done wrong, strategically, and some key issues need to be considered before launching an unbranded off-site blog. Here are a handful:
- Scientists don’t like underhanded marketing. If you’re promoting your company or products and you aren’t forthcoming about self-promotion (for example, neglecting to mention that the blog is written by a company employee or that the blog is funded by your company), scientists will think you are trying to trick them and that will hurt your reputation.
- How will you target the desired audience? I’ve witnessed many of these blogs post information that doesn’t seem to have a well thought-out theme and end up being more general and less focused than the target audience. Remember the ultimate purpose: marketing.
- Set goals, and make sure they’re well-defined. What do you want to achieve? How will you measure success? If the blog isn’t meeting the required metrics, take it down and focus your resources somewhere more worthwhile.
- Have a valid reason for neither incorporating a blog on your main site, nor using your branding in a more prominent manner.
Off-site / unbranded life science blogs can be good marketing tools when used correctly, but all the rules of marketing still apply. Think strategically to make sure that you’re achieving your goals with such a blog.
The life sciences are, almost by definition in being a science, a highly technical field. Most life science products, and certainly life science services, are of a similarly highly technical nature. At the same time, experiments are precious and expensive. In this environment, scientists want to be sure that the products and services they purchase will provide high-quality results, and they are often highly skeptical customers. For many small life science companies which may not have the strong branding or widely adopted products or larger companies, such skepticism can be especially acute. Making customers comfortable enough with your company and products to shake this skepticism can pose a challenge, but there are strategies that small life science companies can leverage to help preempt it. Among the best strategies is to project an image of being an expert in the relevant scientific areas. This requires two things: actually having expert knowledge and understanding, and successfully projecting that knowledge.
Being an expert is often the easier component of the strategy. Chances are if you are creating a product for a particular purpose you already have members on your team who are experts in the the relevant scientific area. There are rare situations where this is not the case, however, and the solution is straightforward – learn. Never will a scientist run from your company faster than if your customer-facing employees don’t know what they’re talking about.
Projecting your expertise is harder. Some customers will contact your company if they have doubts, giving you an opportunity to demonstrate your knowledge and ability to them, however many customers will never contact you in the first place if they question your knowledge and skills in key areas. This requires you to be proactive in projecting your expertise. You need to actively seek out opportunities to show the scientific community that you really are a top-caliber thought leader in your field. How can you do this? There are many ways, and here are a few ideas (this list is nowhere near comprehensive):
- Discuss new research and ideas in your field on social networks
- Present at relevant scientific conferences
- Author or co-author methods papers or other journal articles
- Make compelling presentations of your technology on your website
- Draft white papers
- Maintain a blog where you address current topics in your field
- Create a website with updated information relevant to your life science field
Scientists want to do business with people and companies that it has faith in, and a large part of that is faith that you have sufficient expertise. By effectively projecting the image of an expert, you will simultaneously improve your brand image earn the trust of scientists, effectively making them more willing to do business with you.
Great ideas are precious things. They are the fuel driving innovation, the sustenance of progress, the energy that powers success. Not all great ideas are so great in practice, however. In the life sciences, as in all industries, ideas that are put into action need to be periodically re-evaluated to make sure they are working out to be as good as we thought they were. If they are not, then we would be best off scrapping them and focusing our energy and resources on something else … but life science companies seem to have a very hard time doing so, and this inability is to their detriment.
For your information...
Want to learn more about go / kill decision making? You can read about the stage-gate project management technique, from which go / kill is based, on Wikipedia.
The area where this lack of go / kill is most prominent and has the largest effects is product development. Life science product development projects have well-defined milestones and easily tracked metrics, yet go / kill criteria are usually nonexistent and when they are they are most often poorly defined and almost never strictly obeyed. Put simply, not having such criteria is a poor business practice and not obeying them is a poor business decision. Go / kill criteria are defined based on the risk at any point in time in comparison to the revenue potential. This information, which may be subjective but is still based on the best knowledge and information at the time the criteria is created, tells us whether we are likely to achieve our desired returns at any stage-gate (the point at the project when the go / kill decision is made) if we move forward with the project. If you are unlikely to achieve the desired returns, and resources would be better allocated elsewhere then the kill decision should be made, yet it very rarely is.
It is, to some extent, easy to understand why companies so infrequently utilize stage-gates successfully. Kill decisions are hard to make. In our business culture, killing a project is often interpreted as the project failing and this can cloud the business judgment of those on the team who do not want to appear to have been on a failed project. In practice, recognizing the need for a project kill and implementing it should be commendable, a gesture that the project team are willing to put the greater good of the company as a whole. Unfortunately, this rarely happens. No one ever handed out a “best project kill decision of the year” award. Kills are not seen as an achievement but project completion is, so most often projects push on even in the kind of adversity that makes desired returns extremely unlikely.
Other types of endeavors can benefit from stage-gate type go / kill decision making. For example, marketing campaigns can be periodically re-evaluated for ROI determination. If the ROI is not up to par, the campaign can be killed in favor of another which has a greater likelihood of success. Distributor / supplier relationships can be subjected to go / kill, and because of easily quantifiable metrics these decisions can be very easily gauged. Go / kill gates can even be easily and beneficially applied to the continuation of existing products. There are a multitude of other areas where life science companies can benefit from such gates as well.
Ensuring that resources are allocated to areas providing the greatest benefits is a cornerstone of a successful company. Ongoing projects and processes have a need to be periodically reevaluated to determine if they should be continued or “killed” in favor of other more promising endeavors. Despite this, life science companies rarely use go / kill decisions. Implementation of stage-gates and proper adherence to go / kill criteria will help life science companies ensure that that their resources are more optimally allocated and utilized.
So I ran across Ion Torrent’s / Life Technologies’ spoof of Apple’s “I’m a Mac” commercials, where Ion Torrent rips into the Illumina MiSeq a bit … okay, more than just a bit, the Ion Torrent attempts to pretty much tear apart the MiSeq in comparing it to the PGM. If you haven’t seen it, take a look…
UPDATE: As of 4/11, Ion Torrent has made the video private and it is no longer available for viewing. It seems they didn’t appreciate the mixed feedback they were getting. … UPDATE #2: And as of 4/12 it’s back! I guess Life Technologies decided a little bit of controversy might not be such a bad thing after all.
I commend Life Technologies’ marketing team for their guts to start an advertising war. It’s something rarely seen in the conservative world of life science marketing. If they believe they can out-market Illumina, then this tactic should benefit them long-term assuming they actually succeed in doing so.
That being said, there is a problem… Life Technologies just put a whole lot of cards on the table with that ad.
Part of the reason Apple’s strategy was so successful is, beyond the obvious requirement of getting the audience’s attention, it was a rapid-fire assault of consistent marketing messages highlighting various reasons why a Mac is better than a PC. People wanted to see Apple’s ads – most were very unique, some were funny – and Apple kept them coming. They used them in fantastically creative ways, such as on the New York Times homepage. They were about 30 seconds each and mostly focused on one small aspect, such as a positive review, hardware compatibility, bundled software, security, OS stability, etc. They showed their hand slowly which allowed them to sustain the campaign.
Life Technology / Ion Torrent did not do that. In their minute and twelve second ad, they talk about price, run speed and the 6 month delivery time of a MiSeq. There go your three big competitive advantages, all right there in one ad. Now perhaps this was calculated. Perhaps Life Technologies expects Illumina to pull a Microsoft and have a weak, if any, response, but counting on them to do so would seem premature at this point.
If Life Technologies spoofed the ad well and captivate their audience with this ad, which I think they’ll succeed in doing, then they could have drawn a lot more value from turning a single, highly effective ad into a highly effective ad campaign. They could have continued to engage the audience in the future, releasing a series of ads every month or two for a year. While I could see this video going semi-viral in the scientific community (albeit not nearly as successfully as Bio-Rad’s PCR music video), a sustained campaign could multiply that success. As it stands, especially if they continue to play their cards this quickly, I don’t think they’ll be able to turn this ad into such a sustained marketing campaign. If I’m right, they now need to hope that Illumina doesn’t have too many cards up it’s sleeve.
Illumina, in the meanwhile, needs to not pull a Microsoft. It certainly can. The brand image, while perhaps more polished than Ion Torrent’s, certainly isn’t of an old, dated, out-of-touch behemoth. It can strike back very well with a bit of creativity…
All companies making and / or selling life science tools and services have a product portfolio, but often these portfolios are not viewed in a strategic manner. While aligning current company competencies with current marketplace needs is a simple way to have successful products, a broader view of the product or service portfolio is necessary to ensure greater corporate, and long-term, success. In this post, I’ll go over some of the broader considerations of managing a product portfolio.
Note that many companies discuss product portfolio management to effectively be the new product development project selection process. While new product development project selection is an important part of product portfolio management, I believe this viewpoint to be too narrowly focused, as existing products need to be factored into portfolio management as well, and there are issues related to portfolio management that are indeed independent of new product development. I will discuss new product development project selection in more depth in a later post, as it is a critical business process, but for this post I will simply try to address some common questions relating more globally to product portfolio management in the life sciences.
How many products are the right amount?
Deciding how many products should be in your product portfolio is a difficult question, but there is a correct answer that requires balancing a multitude of factors. First of all, and arguably most importantly, is the amount of products that you can profitably develop. If you have the skills and the market need exists for more products, then building more is usually a good idea. Also important, however, are risk and the scope and goals of the company. If your product portfolio is too small or too narrow, then you may be exposing yourself to a large amount of risk by putting too many eggs in one basket, so to speak. On the other hand, if you have too many products you may lose focus of your scope and your goals, or simply lose the ability to effectively maintain or all of your product lines.
Should product X be in our product portfolio?
Again, if you have the skills to build a given product and the market need exists for it, then it is usually a good idea to build it. Before diving in head first, however, be sure you know the opportunities and threats of doing so. Also, if a given product is sufficiently outside the rest of your product portfolio, then other problems may arise. Your customers not view you as having a competency in that area and this can hurt customer confidence in that particular product or product line, adversely affecting sales. Furthermore, a disparate product from others in your portfolio may incur large marketing cots, as the effective economies of scale achieved by co-marketing (effectively marketing for many products at once) may not exist. For older products, you periodically need to ask if the product is still worth supporting. This should not be a simple question of if the product is obsolete, however, but rather will the profits from making or selling the product meet the desired rate of return. Ultimately, strategy and rate of return are the most important deciding factors in deciding if a product should be developed, maintained, or scrapped.
How do I know my product portfolio has the right mix of products?
Your developed product portfolio should accurately reflect your core competencies and the current needs of the life science research market while your product development projects should be addressing anticipated future needs. Make good use of market research to figure out exactly what those needs are with respect to your business.
Notes for life science distribution companies
If you’re a life science distribution company your job of product portfolio management is in many ways much simpler since you have no product development costs. However, there are still costs associated with bringing on a new product or product line, so having as large an offering as possible is often not a good strategy. Also, consider your strategic positioning within the life science marketplace and align your product offerings to that positioning. If your strategy involves certain segments of the life science market, leverage your product portfolio to gain a reputation as an expert “go-to” seller within that market segment. Since you have less variables to deal with than manufacturers, fully-quantitative, even automated, processes for dealing with portfolio management processes are also sometimes possible.
Effectively managing your product portfolio will not only ensure that your business is profitable in the short- and mid-term, but by aligning with strategies and goals can help lead your bioscience company to long-term success.
Life scientists are busy people. Between bench work, meetings, writing, presentations, seminars, and everything else they may have to do in their day, their time is limited. As such, they appreciate (knowingly or not) situations where the purchasing of products that they need is easy, fast, and simple. While the ease of the purchasing process is usually not so important as to change the mind of someone who has decided on purchasing a given piece of lab equipment, antibody, reagent, or other bioscience product, it can easily sway the undecided buyer one way or the other. By identifying and lowering or removing the barriers to purchasing your laboratory products or services, you can sway those undecided minds in your life science company’s favor.
This is a bit of an oversimplification, but for brevity’s sake we can break down the sales process, from the eyes of the customer, into three steps:
- Finding your product / service
- Obtaining the desired information
- Acting on the desire to purchase
The first step is arguably the most important. It should go without saying that unless scientists can find your product, they are not going to buy it. Getting found is a multi-faceted issue that has no single solution, but rather many different potential solutions that can be used in combination based on your company’s situation. Having distributors list your products in catalogs, traditional marketing campaigns via print advertising in scientific journals, banner advertising on relevant websites, e-mail campaigns, search engine marketing, social media marketing, search engine optimization, word of mouth marketing, and utilizing in-house sales teams are all options with different benefits and drawbacks and a unique mix of any of these may be appropriate for your company and product (note that this list is not meant to be exhaustive). Identify how you can maximize your exposure in a cost-effective manner and implement those solutions so your life science products are easily found.
No matter how a customer finds your product or service, you always need to make sure you provide them with the desired information to get them interested in buying. As a general rule, more information is better so long as it is well-organized, relevant, and positive. Use this information to keep them engaged the entire time they browse it. Any time a researcher wants more information about your product but doesn’t find it is an opportunity for them to walk away or look for different products, so even if in formats not well suited to containing large amounts of information, the location of additional information should be given and this information should be as easily accessed as possible. A key component to this, since it will almost inevitably contain the most information about your products or services, is having a website with all the necessary product information laid out in an easily navigable way. (you can learn more about streamlining your website for additional sales here)
Lastly, the ability to act on the desire to purchase should be a fast, simple, and easy process (or at least as much is plausible given the nature of the product or service). For example, if your product does not require a quote-driven sales process, e-commerce allows your customers to order quickly and easily. Online forms for quote requests or demonstration requests are similarly low barriers to action. Where possible, free samples are a great way to get your products in front of the customer. If the customer needs to contact your company, let them do it in the manner that they prefer to, be it e-mail, phone, a simple contact form, etc. to ensure that they are comfortable establishing the necessary communication to further the sales process.
Scientists, lab managers, purchasers, and procurement agents all prefer simple and streamlined sales processes, and reducing the barriers to purchasing your bioscience product can be an easy way to increase your conversion. While the ease of the purchasing process is most often not important enough to the customer to change a purchasing decision altogether, it can easily sway the undecided buyer one way or the other. By streamlining your sales process, you can tilt those undecided buyers in your favor and increase your life science sales.
Branding is an important part of marketing in the life sciences, as we’ve previously discussed in this blog. The ability to shape and manage the perceptions of your company in the minds of customers is a powerful thing. Simply having strong branding will certainly help your company in a multitude of ways, but you can do even more and leverage your brand to derive even more value from it. One such way is the cultivation of brand champions.
What is a brand champion?
A brand champion is someone who feel strongly about your brand, understands its message, and promotes it to others. You could say that brand champions are the “stewards” of your brand. While brand champions can be any stakeholder, we’re going to focus on customers as brand champions. Having customers as brand champions is of particular value.
How to Cultivate Brand Champions
Every brand champion starts as an enthusiast. Find customers who like your products and / or brand and have given you good feedback or maybe who your support or sales staff have a good relationship with. Pick customers who can identify with and support your brand values and goals. Once these customers are identified, define and execute strategies that improve engagement with those customers on a personal level. Give them that little bit of special treatment. Once your enthusiasts are engaged, be sure you have communicated the brand values to them. While there are many strategies to perform any one of these steps, so long as they are performed you’ll start creating brand champions out of your customer enthusiasts.
Leveraging Brand Champions
Once you’ve cultivated your brand champions you can leverage the value that you have created in doing so. One common way to extract value from your brand champions is by encouraging word-of-mouth marketing. Word-of-mouth marketing is both free and highly effective – your marketing message will be much more readily accepted by scientists when it comes from a colleague. (Curious how you can encourage word-of-mouth marketing among your customers or brand champions? Ask us.)
Brand champions are also great beta-testers. Have a product you’d like user feedback on before a full release? Ask your brand champions if they’d be interested in trying it out. Brand champions can be trusted to provide quality feedback and not be overly negative to colleagues about any flaws or unfinished aspects of your new product.
Testimonials and referrals are also great ways to derive value from brand champions. Scientists are more accepting of other products when they hear positive things from other researchers / customers regarding the quality of the product, the services of the company, etc, and brand champions will much more readily be the customers that flout your benefits to others.
Brand champions will also help you crowdsource. When you need the opinions of your customers, your enthusiastic brand champions will be right there to help you and provide the feedback or perspective you need.
There are more ways to leverage brand champions as well. No matter how you do so, be sure that your brand champions feel good about the interaction with your company and brand. If they begin to feel like they are simply being used or taken advantage of they’ll turn their cheek to your brand and you’ll lose a loyal champion. Don’t let that happen. Be sure your brand champions feel properly rewarded.
Cultivating customers into brand champions requires effort but is highly rewarding. Brand champions can be a strategic advantage to your business and provide unique value to your company that cannot be derived in other ways.